From candidate to default: the company has just been placed inside buyers' own purchasing systems
The model's full reasoning — Q3 2018 call → NOWe need answer YES/NO. Need analyze transcript. Question asks: Does management describe that company has recently crossed from candidate to approved/specified/listed/qualified/etc inside buyers' purchasing systems, so future business can arrive without discrete selling, and that status is new enough most volume still ahead? Need identify in transcript. Transcript: Jay Sidhu discusses strategic priorities. Mentions "white label partnership" with T-Mobile? BankMobile white label deposits. "We expect significant growth in low cost BankMobile white label deposits starting sometime in next year, and we think that within 12 months after the launch of our relationship with our white label partner, which is T-Mobile, that we expect deposits to be about $500 million, and these will be very low cost deposits." Also "BankMobile new white label partnership" and "grow BankMobile for next two to three years before spin off." Also "launched CB digital bank" direct bank. But question specifically about being placed into buyer's purchasing/reimbursement/formulary etc. White label partnership? Is that a "buyer-side system" where company becomes default? White label means BankMobile provides banking services under T-Mobile brand? That could be a distribution partnership where T-Mobile offers to its customers, so deposits arrive without discrete selling? But is it "approved, specified, listed, qualified, registered, reimbursed, pre-authorized" inside buyers' own systems? White label partnership is a contractual arrangement where the partner (T-Mobile) offers BankMobile's product to its customers. That is a distribution channel, not necessarily a "formulary" or "purchasing pathway." The question asks: "the company has moved from candidate toward default inside the routine pathway through which purchases get made." White label partnership could be such: T-Mobile's customers get BankMobile as default? But management says "after the launch of our relationship with our white label partner" - not yet launched? "starting sometime in next year" and "within 12 months after the launch" - so status is pending, not yet obtained. Also "we expect" - future. So NO because not yet in place, only expected. Also "CB digital bank" launched in Q3, generating deposits. That's a new product, not a gateway. Also "BankMobile deposits continued to increase" - not a gateway.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| WRBY | Warby Parker Inc. | Q1 2024 | 2024-05-09 | A |
| AZEK | The AZEK Company Inc. | Q2 2024 | 2024-05-08 | B+ |
| DXCM | DexCom, Inc. | Q4 2023 | 2024-02-08 | B+ |
| SCPH | scPharmaceuticals Inc. | Q3 2023 | 2023-11-08 | B |
| INGN | Inogen, Inc. | Q1 2023 | 2023-05-05 | F |
| HBB | Hamilton Beach Brands Holding Company | Q3 2022 | 2022-11-05 | C |
| EVGO | EVgo, Inc. | Q2 2022 | 2022-08-09 | C+ |
| OPK | OPKO Health, Inc. | Q1 2022 | 2022-05-09 | D |
| MGNI | Magnite, Inc. | Q1 2022 | 2022-05-04 | D |
| AGIO | Agios Pharmaceuticals, Inc. | Q3 2018 | 2018-11-01 | C |
| PRIM | Primoris Services Corporation | Q2 2018 | 2018-08-11 | C+ |
| IONS | Ionis Pharmaceuticals, Inc. | Q1 2017 | 2017-05-09 | C |
PRIM · Q2 2018 → YESThe question is about whether management describes that the company has recently crossed from being a candidate that buyers must be persuaded to consider into being an approved, specified, listed, qua...YES The transcript shows management describing exactly this shift for the newly acquired T&D segment: after the Willbros acquisition (closed June 1, 2018), the T&D Group gained access to major utilities that had been hesitant due to prior financial concerns. With Primoris as parent, they signed new awards from the 3 largest electrical utilities (one announced MSA, two not yet announced), allowing work to flow under existing relationships without repeated persuasion. Management explicitly ties this to the recent acquisition and notes the MSA backlog now at $1.1 billion (first time exceeding $1 billion), with one-year estimated MSA revenue at $1.1 billion and continued growth expected.
AGIO · Q3 2018 → YESThe question is about whether management describes that the company has recently crossed from being a candidate that buyers must be persuaded to consider into being an approved, specified, listed, qua...YES The transcript shows management describing exactly this transition for TIBSOVO. Steve Hoerter states that the company launched in July 2018 and is now receiving reimbursement with “no payer-related coverage issues,” with the payer mix (60% Medicare, 35% commercial) reflecting routine placement in those systems. He further notes that initial prescriptions are being written by over 100 unique prescribers and that awareness is already above 90%, confirming the product has moved from candidate status into the reimbursement and purchasing pathways. Because the launch is only a few months old at the time of the call, the $4.
AZEK · Q2 2024 → YESThe question is about whether management describes that the company has recently crossed from being a candidate that buyers must be persuaded to consider into being an approved, specified, listed, etc...YES The transcript shows management describing recent and incremental shelf-space gains in both pro and retail channels as a new development that will support growth in 2025, with investments planned for Q4 to enable these gains. This is framed as moving beyond prior years' steady execution into fresh wins that create a tailwind for future 2025 volume, where the company is now positioned to benefit from expanded availability in buyer systems (catalogs, dealer networks, and retail displays) without needing to re-persuade for each order.